Genedant

RyboDyn is a biotechnology research company focused on developing innovative therapeutics aimed at training the immune system to detect and eliminate cancer from within the body. The company is dedicated to advancing scientific breakthroughs that lead to new classes of treatments, providing significant improvements in medicine. RyboDyn's work is particularly concentrated on creating upgraded therapies for serious diseases, including terminal conditions, with the goal of enhancing patient outcomes and expanding treatment options.

Auristone is a company that specializes in developing an epigenetics platform aimed at analyzing cancer patients, particularly focusing on Asian cancers. The platform utilizes proprietary workflows and predictive models to provide actionable clinical insights and analyses based on epigenomic information. By offering demonstrable clinical evidence and meaningful correlations with other diseases, Auristone enables clinicians to make informed decisions regarding the most appropriate treatments for advanced cancers. This approach supports the principles of personalized medicine, ultimately enhancing patient care through tailored therapeutic strategies.

Fable Food Co is a company that specializes in creating plant-based meat alternatives primarily derived from shiitake mushrooms. Their products are designed to replicate the taste and texture of traditional meat, providing a nutritious and healthy substitute for consumers. Fable's offerings are clean label and minimally processed, made entirely from natural plant-based ingredients. The company's products are widely available across Australia, including major retailers such as Harris Farm Markets, Coles, and Woolworths, as well as through meal delivery services like Marley Spoon and Dinnerly. Additionally, Fable's products feature on various restaurant menus in Australia, Singapore, and the UK, catering to both food enthusiasts and those seeking vegan options.

Umami Bioworks is a company focused on the discovery and development of a scalable platform for producing cultivated seafood, aiming to protect endangered marine species while providing consumers with sustainable seafood options. The company utilizes systems engineering to enhance the discovery and industrialization processes, facilitating local production that is both price competitive and environmentally responsible. Its innovative approach involves creating cell-based food products derived from fish cells and tissue, which are designed to be free from harmful substances such as mercury, antibiotics, microplastics, and ocean pollutants. By offering affordable, cell-cultured seafood and meat alternatives, Umami Bioworks addresses the growing demand for healthy and sustainable food choices.

Sequential Skin is a diagnostic platform focused on skin longevity and aging, leveraging expertise in genetics, epigenetics, and the skin microbiome. The company specializes in clinical microbiome testing for skin, scalp, and female health. Its primary offering is a skin health test that employs quantitative real-time PCR (qPCR) technology to analyze specific markers within the skin microbiome. This analysis provides individuals with a detailed understanding of their skin profile, helping them identify their unique skincare needs. By delivering personalized insights, Sequential Skin empowers individuals to make informed decisions about their skincare routines.